Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: December 2019
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 4 of 4 items.
GILENYA (fingolimod) - Risk of Congenital Malformations
AlertHealth professional risk communication | 2019-12-19
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
Health Canada clarification: laser-based medical devices are not licensed in Canada to cure fungal nail infections
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02